| Novo Nordisk AS | ||
|---|---|---|
| Target — | Outlook Short / Sell | Market Price (at time of publication) 55.29 EUR |
Analysis statistics – Last 12 months
2,713 Total analyzed
Bullish 388 (14.3%)
Bearish 96 (3.5%)
Neutral 2,229 (82.2%)
| CTS Eventim AG & Co. KGaA | ||
|---|---|---|
| Target — | Outlook Neutral | Market Price (at time of publication) 102.90 EUR |
| Nordex SE | ||
|---|---|---|
| Target — | Outlook Long / Buy | Market Price (at time of publication) 15.90 EUR |
| TecDAX | ||
|---|---|---|
| Target — | Outlook Neutral | Market Price (at time of publication) 3,588.29 Points |
| Take-Two Interactive Software Inc. | ||
|---|---|---|
| Target 250.00 USD | Outlook Long / Buy | Market Price (at time of publication) 225.38 USD |
| DAX – Deutscher Aktienindex | ||
|---|---|---|
| Target — | Outlook Neutral | Market Price (at time of publication) 22,362.70 Points |
| Dow Jones Industrial Average Index | ||
| Target — | Outlook Neutral | Market Price (at time of publication) 40,106.40 Points |
| MDAX – Mid-Cap-DAX | ||
| Target — | Outlook Neutral | Market Price (at time of publication) 28,310.80 Points |
| NASDAQ 100 Index | ||
| Target — | Outlook Neutral | Market Price (at time of publication) 19,426.70 Points |
| S&P 500 Index | ||
| Target — | Outlook Neutral | Market Price (at time of publication) 5,520.75 Points |
| TecDAX | ||
| Target — | Outlook Neutral | Market Price (at time of publication) 3,596.20 Points |
| EURO STOXX 50 | ||
| Target — | Outlook Neutral | Market Price (at time of publication) 5,186.34 Points |
| Sanofi S.A. | ||
|---|---|---|
| Target — | Outlook Neutral | Market Price (at time of publication) 93.11 EUR |
| Alphabet Inc. | ||
|---|---|---|
| Target — | Outlook Neutral | Market Price (at time of publication) 161.47 USD |
| Alphabet Inc. A | ||
| Target — | Outlook Neutral | Market Price (at time of publication) 159.28 USD |
| ServiceNow Inc | ||
|---|---|---|
| Target — | Outlook Neutral | Market Price (at time of publication) 938.57 USD |
| Euro / US-Dollar | ||
|---|---|---|
| Target — | Outlook Neutral | Market Price (at time of publication) 1.14 |